Belgium Takes Centre Stage at GITEX AI Asia as European Health Tech Ambitions Go Global

Why Healthcare AI Is Belgium's Export Story

Belgium punches above its weight in life sciences and medtech. The country hosts the European headquarters of several major pharmaceutical groups, a dense cluster of university hospital systems, and imec, the Leuven-based nanoelectronics and digital technology research centre that sits at the intersection of semiconductor design and medical imaging hardware. Imec's work on AI-accelerated chip architectures for medical devices gives Belgium a credible technical narrative to present to Asian enterprise buyers evaluating European technology partnerships.

The health AI conversation at GITEX Digi Health and Biotech is not abstract. Agentic AI systems are already demonstrating measurable performance improvements in clinical settings, automating radiology triage, flagging drug interaction risks, and supporting early-stage pharmaceutical screening. For Belgium, Singapore is a logical gateway: the city-state's hospital networks and its regulatory environment for digital health are among the most advanced outside Europe, and the partnerships formed at events like this one tend to produce concrete procurement decisions within twelve to eighteen months.

European Regulatory Confidence as a Competitive Advantage

One argument Belgian and wider European delegations are making forcefully to Asian partners is that the EU AI Act is not a burden but a differentiator. Enterprises in regulated sectors, including hospitals, insurers, and pharmaceutical companies, increasingly want AI systems that arrive pre-certified against a credible legal framework. Thierry Breton, the former European Commissioner for the Internal Market, consistently argued during his tenure that the EU's regulatory rigour would become a global export, a set of standards that third-country firms would adopt voluntarily to access European procurement contracts. That thesis is now being tested in practice at events precisely like this one.

Equally relevant is the work coming out of ELIXIR, the European intergovernmental organisation coordinating life-science data infrastructure across 23 member states, including Belgium. ELIXIR's federated data-sharing model is directly applicable to the cross-border health AI deployments that Asian hospital networks are beginning to consider. The organisation's technical frameworks for data sovereignty and patient privacy align closely with what enterprise buyers in Singapore and beyond are now demanding from their AI vendors.

Infrastructure, Skills, and the Governance Gap

Beyond healthcare, the broader GITEX AI Asia programme reflects pressures that European technology leaders will recognise immediately. Enterprise buyers across multiple sectors are moving decisively from AI pilots into production deployments. The gap between organisations that have successfully scaled AI and those still cycling through proof-of-concept projects is widening, and the conference's central argument is that the infrastructure layer, meaning compute, data centres, and sovereign cloud capacity, is the decisive variable.

Industry projections suggest that global data centre capacity will need to roughly double within five years to support current AI adoption trajectories. European hyperscalers and colocation operators are watching the Asian infrastructure build-out closely. Microsoft, Google, and a range of European operators including Equinix's European division are all expanding capacity in northern and central Europe to serve AI workloads, and the governance questions around data residency and sovereignty that dominate policy discussions in Brussels are equally live in Singapore and across Southeast Asia.

Skills development is the third pillar of the agenda. Nanyang Technological University's integration of AI tools across its student curriculum mirrors moves being made at ETH Zurich and KU Leuven, both of which have embedded AI literacy requirements across undergraduate programmes. The European analogy is instructive: institutions that move early on AI education tend to produce the talent pipelines that attract enterprise investment within a decade.

Conference Thematic Streams

The full GITEX AI Asia 2026 programme addresses the following priorities, each of which has a direct European counterpart in current policy and enterprise strategy:

• Enterprise AI adoption and workflow automation across sectors
• Cloud infrastructure, data centre expansion, and data sovereignty requirements
• Cybersecurity, compliance, and responsible AI governance frameworks
• Quantum computing research and near-term applications in finance and materials science
• Healthcare AI and agentic systems in diagnostics and treatment planning
• Skills development and workforce readiness for AI-driven roles
• Investment and fundraising opportunities for emerging technology companies

For European enterprises evaluating whether events like GITEX AI Asia belong on their international engagement calendar, Belgium's pavilion debut offers a clear answer. The partnerships being structured this week in Singapore will shape procurement decisions, infrastructure investments, and regulatory alignments that affect European health technology markets directly. Sitting out global AI summits because they are geographically distant is a strategy that produces exactly the market position European firms can least afford: invisible.